Trial Profile
A cross-sectional, multicenter, observational study of perampanel in real life in Germany and Austria.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Sep 2015
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- 25 Sep 2015 New trial record